Pharmaceutical Prevention and Management of Cardiotoxicity in Hematological Malignancies

Modern treatment modalities in hematology have improved clinical outcomes of patients with hematological malignancies. Nevertheless, many new or conventional anticancer drugs affect the cardiovascular system, resulting in various cardiac disorders, including left ventricular dysfunction, heart failu...

Descripción completa

Detalles Bibliográficos
Autores principales: Perpinia, Anastasia Stella, Kadoglou, Nikolaos, Vardaka, Maria, Gkortzolidis, Georgios, Karavidas, Apostolos, Marinakis, Theodoros, Papachrysostomou, Chrysostomi, Makaronis, Panagiotis, Vlachou, Charikleia, Mantzourani, Marina, Farmakis, Dimitrios, Konstantopoulos, Konstantinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412591/
https://www.ncbi.nlm.nih.gov/pubmed/36015155
http://dx.doi.org/10.3390/ph15081007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412591/
https://www.ncbi.nlm.nih.gov/pubmed/36015155
http://dx.doi.org/10.3390/ph15081007

Ejemplares similares